Valeo Financial Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-45
Closed -$6K 562
2021
Q1
$6K Sell
45
-2
-4% -$301 ﹤0.01% 1488
2020
Q4
$6K Hold
47
﹤0.01% 1310
2020
Q3
$7K Sell
47
-66
-58% -$9.38K ﹤0.01% 1156
2020
Q2
$17K Hold
113
﹤0.01% 1109
2020
Q1
$13K Buy
113
+64
+131% +$7.39K ﹤0.01% 991
2019
Q4
$6K Hold
49
﹤0.01% 1217
2019
Q3
$4K Hold
49
﹤0.01% 1223
2019
Q2
$4K Sell
49
-7
-13% -$537 ﹤0.01% 1239
2019
Q1
$5K Hold
56
﹤0.01% 1136
2018
Q4
$4K Hold
56
﹤0.01% 1116
2018
Q3
$4K Buy
56
+5
+10% +$503 ﹤0.01% 1247
2018
Q2
$5K Hold
51
﹤0.01% 1114
2018
Q1
$6K Hold
51
﹤0.01% 1061
2017
Q4
$6K Hold
51
﹤0.01% 948
2017
Q3
$6K Buy
+51
New +$4.35K ﹤0.01% 813

Other funds holding ALNY